Back to top
more

Molina Healthcare (MOH)

(Delayed Data from NYSE)

$327.48 USD

327.48
408,609

-3.64 (-1.10%)

Updated Sep 6, 2024 04:00 PM ET

After-Market: $327.85 +0.37 (0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (212 out of 249)

Industry: Medical - HMOs

Better trading starts here.

Zacks News

Integra's (IART) Q4 Earnings Top Estimates, Gross Margin Drops

Integra (IART) records strong recovery in order demand in Q4 on broad-based strength in Neurosurgery and sales from the company's new CereLink ICP monitoring.

Fresenius Medical (FMS) Q4 Earnings Beat Estimates, Up Y/Y

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strong performance across all the geographic regions and segments.

Glaukos (GKOS) Q4 Earnings and Revenues Surpass Estimates

Despite reporting a fourth-quarter loss, Glaukos' (GKOS) results reflect a noticeable rise in revenues.

Exact Sciences (EXAS) Q4 Revenues Top Estimates, Margin Down

Exact Sciences' (EXAS) legacy Screening business saw strong momentum on solid Cologuard volume growth during the fourth quarter.

Tandem Diabetes (TNDM) Q4 Earnings Lag Estimates, Revenues Top

Robust domestic and international pump shipments are driving Tandem Diabetes' (TNDM) fourth-quarter top line.

Charles River (CRL) DSA Arm Sees Growth, Cell Supply Sluggish

The acquisitions of Cognate BioServices and Vigene Biosciences contribute to the growth of Charles River's (CRL) Manufacturing Solutions arm.

Medtronic's (MDT) Q3 Earnings Beat, Revenues Lag Estimates

Medtronic (MDT) registers organic growth in the Cardiovascular, Neuroscience and Diabetes segments in Q3.

Henry Schein (HSIC) Up 10.1% Since Posting Q4 Earnings Beat

Henry Schein (HSIC) stock rallies on strong fourth-quarter performance and bullish 2022 EPS guidance.

Shockwave Medical (SWAV) Gains 3.2% Post Q4 Earnings Beat

Shockwave Medical's (SWAV) fourth-quarter results reflect robust revenue growth and expansion in gross margin.

UnitedHealth Group (UNH) Bolsters Presence With Contract Win

UnitedHealth Group's (UNH) unit UnitedHealthcare receives a contract from the District of Columbia aimed at improving health outcomes of District Dual Choice program enrollees in the district.

AMN Healthcare (AMN) Q4 Earnings and Revenues Top Estimates

AMN Healthcare's (AMN) robust Q4 results demonstrate its segmental strength.

Syneos Health (SYNH) Q4 Earnings Top Estimates, Margins Down

Syneos Health (SYNH) reports better-than-expected earnings for the fourth quarter and strong performances by the Clinical Solutions and Commercial Solutions arms.

Globus Medical (GMED) Q4 Earnings Top Estimates, Gross Margin Up

Strength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues.

Here's How Much You'd Have If You Invested $1000 in Molina a Decade Ago

Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.

Baxter (BAX) Q4 Earnings and Revenues Surpass Estimates

Baxter's (BAX) fourth-quarter results reflect robust performance across six of its business units.

West Pharmaceutical (WST) Q4 Earnings & Revenues Top Estimates

West Pharmaceutical's (WST) fourth-quarter earnings reflect strength in the Proprietary Products segment and margin expansion.

Should Invesco S&P MidCap Quality ETF (XMHQ) Be on Your Investing Radar?

Style Box ETF report for XMHQ

Charles River (CRL) Q4 Earnings Beat Estimates, Margins Up

Robust demand for research models, particularly in China, as well as higher revenues from research model services aid Charles River (CRL) in Q4.

Alcon's (ALC) Q4 Earnings Top Estimates, Margins Increase

According to Alcon (ALC), strong product flow results in above-market revenue growth, which drives core operating leverage and margin expansion.

Masimo's (MASI) Q4 Earnings Surpass Estimates, Margins Up

Masimo's (MASI) robust product shipments, along with strong sensor sales, drive its Q4 sales.

PacBio's (PACB) Q4 Earnings Miss Estimates, Revenues Top

PacBio (PACB) sees strength in Q4 segmental revenues, led by robust consumable and instrument sales.

Mednax (MD) Pursues $1.1B Transactions to Reduce Debt Burden

Mednax (MD) issues senior notes, and a new revolving credit facility coupled with a term loan remains in place, which is aimed at reducing MD's debt level and associated interest expenses.

Is Aptinyx Inc. (APTX) Outperforming Other Medical Stocks This Year?

Here is how Aptinyx Inc. (APTX) and Molina (MOH) have performed compared to their sector so far this year.

Humana (HUM) to Support Eligible Medicaid Members in Louisiana

Humana (HUM) is picked by the Louisiana Department of Health for a contract win to help serve the Medicaid members in Louisiana.